Future of pharma's commercial model | Deloitte Insights
The biopharmaceutical industry’s commercial model has been an important part of each company’s success, but the current capabilities and strategies are unlikely to suffice for future …
Trust in biopharma during COVID-19 | Deloitte Insights
May 6, 2021 · Consumers may appreciate pharma companies’ efforts to speed up the process of bringing COVID-19 vaccines to market. How might biopharma continue to innovate while …
AI In Biopharma Collection | Deloitte Insights
Artificial intelligence-enabled technologies are transforming the different parts of the biopharma industry value chain, creating new business opportunities. Explore Deloitte's collection of …
M&A trends in life sciences: Deal-making in 2022
Inorganic growth activity in life sciences— have we reached the bottom? Our previous report outlined a steep decline in life sciences deal-making in the first half of 2022 from record levels …
Deloitte US | Together Makes Progress
Discover industry insights and audit, tax, and consulting services that drive impact from Deloitte’s global network of member firms.
バイオ医薬品における新規モダリティと周辺市場の形成 | デロイ …
Apr 10, 2024 · バイオ・創薬スタートアップは新規モダリティの創出の原動力であり、ひとたび新規モダリティが上市されると、それらは大きな市場を形成し、同時に業界構造についても …
Deloitte US | Audit, Consulting, Advisory, and Tax Services
Deloitte US | Audit, Consulting, Advisory, and Tax Services
2025年度版「グローバル自動車消費者意識調査」 | デロイト トー …
2024年10月から11月にかけて実施された2025年度版グローバル自動車消費者調査では、次の4つの主要なトレンド取り上げる。 ほとんどの市場でバッテリー式電気自動車（BEV）への関心 …
218668_2019 Global Life science_Infographic v3 28-1-2019 Full
More than 3/4 of biopharma companies agree that their organizations need new leaders to succeed in the digital age. Many companies are recruiting outside of life sciences for digital …
Business insights, analysis & perspectives | Deloitte Insights
Deloitte Insights delivers research, analysis, and perspectives for business and government.
Skip to content